
engelsk
Teknologi og vitenskap
99 kr / Måned etter prøveperioden.Avslutt når som helst.
Les mer Exploration Science with Dr. Wendy Hartsock and Dr. Diedra Shorty
Exploration Science is a discussion-based interview series in which scientists talk about their ventures and areas of expertise to educate and inspire other scientists. Join CEM's Dr. Wendy Hartsock and Dr. Diedra Shorty as they interview brilliant researchers to discuss peptides, proteins, and cutting-edge science.
Bringing Biochemistry to Peptide Production
In this episode of Exploration Science, CEO and Co-founder of Numaferm, Dr. Christian Schwarz, and peptide manufacturing expert, Dr. Alain Scarso, discuss the peptide therapeutics market and dive into the technology of Numaswitch – a transformative biochemical platform to produce peptides, pepteins, and proteins.
Accelerating Peptide Therapeutics with Biocomputational AI
In this episode of Exploration Science, Pepticom co-founders, Dr. Immanuel Lerner and Dr. Amit Michaeli, discuss the advantage of employing biocomputational AI software to optimize peptide drug discovery, reduce development risks, and accelerate time to market.
The Design, Synthesis, and Study of Biologically Relevant Peptides
In this episode of Exploration Science, Dr. James Nowick (University of California, Irvine) and Dr. Nick Truex (University of South Carolina) delve into the complexities of designing, synthesizing, and examining biologically significant peptides. They also share fond memories of their time working together in the lab.
Intelligently Navigating the Peptide Chemical Space
In this episode of ExplorationScience, Dr. Jonathan Steckbeck, the founder and CEO of Peptilogics, discusses the company's approach to peptide drug discovery. Tune into this episode to learn how partnering biology with machine learning is guiding the intelligent navigation of peptide chemical space to develop next-generation therapeutics.
De Novo Protein Biosensors: Transforming Point of Care
In this episode of Exploration Science, Dr. David Shoultz, Chief Operating Officer & Co-Founder of Monod Bio discusses the next generation of clinical diagnostics and how the company is transforming point of care for patients. Tune in and learn how scientists at Monod Bio are driving diagnostic innovation through de novo protein design and deploying lucCage technology. This platform is based on research conducted by Dr. David Baker and scientists at the University of Washington Institute for Protein Design to generate artificial luciferases with optimized size, stability, substrate specificity, and photophysical properties.
Velg abonnementet ditt
Mest populær
Premium
20 timer lydbøker
Eksklusive podkaster
Ingen annonser i Podimo shows
Avslutt når som helst
Prøv gratis i 14 dager
Deretter 99 kr / måned
Premium Plus
100 timer lydbøker
Eksklusive podkaster
Ingen annonser i Podimo shows
Avslutt når som helst
Prøv gratis i 14 dager
Deretter 169 kr / måned
Prøv gratis i 14 dager. 99 kr / Måned etter prøveperioden. Avslutt når som helst.